Crossmark

Metabolic syndrome including both elevated blood pressure and elevated fasting plasma glucose is associated with higher mortality risk: a prospective study

Crossref DOI link: https://doi.org/10.1186/s13098-025-01628-5

Published Online: 2025-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Shu

Wen, Chi Pang

Tu, Huakang

Wang, Sicong

Li, Xue

Xu, Andi

Li, Wenyuan

Wu, Xifeng https://orcid.org/0000-0001-5174-3769
Funding

Funding for this research was provided by:

Zhejiang Key Laboratory of Intelligent Preventive Medicine

Healthy Zhejiang One Million People Cohort (K20230085)

the Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang (2019R01007)

Cancer Center, Zhejiang University and Key Research and Development Program of Zhejiang Province (2020C03002)
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Received: 14 October 2024

Accepted: 3 February 2025

First Online: 25 February 2025

Declarations

:

: Informed consent was obtained to authorize data processing and analysis. Ethical reviews were approved by the Institutional Review Boards at the Taiwan Health Research Institutes. Individually identifying data were removed and remained anonymous during the entire study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below